Status:
COMPLETED
Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)
Lead Sponsor:
Takeda
Conditions:
Gastroesophageal Reflux Disease (GERD)
Peptic Ulcers
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Gastroesophageal reflux disease (GERD) is a medical condition affecting the stomach and esophagus. GERD might occur when the lower esophageal sphincter does not close properly and stomach contents lea...
Eligibility Criteria
Inclusion
- Main
- Patients who completed ALTANA Pharma study BY1023/FK3006 (long-term clinical trial regarding efficacy and tolerability of Pantoprazole in patients not responding to treatment with H2-receptor antagonists or omeprazole)
- Written informed consent
- Main
Exclusion
- Concomitant diseases
- Pregnant or nursing female patients; female patients of childbearing potential who are not using reliable contraception
Key Trial Info
Start Date :
October 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00261300
Start Date
October 1 2000
End Date
July 1 2008
Last Update
May 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Altana Pharma/Nycomed
Hanover, Germany, 30659